Germany prostate cancer market is forecast to grow at a CAGR of 11.5% during the forecast period. The high prevalence of prostate cancer in the country is one of the major factors for the demand for prostate cancer diagnostics services and therapeutics. As per the World Health Organization, around 63,000 new cases of prostate cancer were registered in 2018. Cancer has the highest share of all cancer among men in the country with around 19% of the overall cases. The 5-year prevalence in the country due to prostate cancer is around 233,000 in 2018. 

Moreover, the increasing geriatric population, the presence of highly specialized urologists for prostate cancer treatment are contributing to the growth of the market. Around 90% of the German population is insured by the statutory health insurance (SHI). Regardless of the type of health insurance, all beneficiaries have access to an outpatient physician and non-physician services, hospital care, rehabilitation, dental care, prescription drugs, medical supplies and long-term nursing care.  

The presence of renowned clinics and treatment centers in the country is another major factor for the growth of the market as it is augmenting medical tourism. Martini Klinik is one of the largest prostate cancer clinics all across the globe that caters to more than 5,000 outpatient cases and 2,400 surgical cases seen every year. The presence of highly skilled doctors and urologists in Germany attracts many patients to the country for receiving treatment procedures. For instance, each surgeon at Martini Klinik conducts between 200 and 300 procedures per year. 

Germany prostate cancer diagnostic and therapeutic market has been studied on the basis of diagnostic techniques and therapeutics. By diagnosis technique, prostate biopsy is expected to hold a major market share during the forecast period. By therapeutics, chemotherapy is expected to have a major market share in the country. The companies which are contributing significantly in the market include Abbott Laboratories, AbbVie Products, LLC, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., Siemens Healthcare AG and others. The market players are considerably contributing to the market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.

Research Methodology

The market study is incorporated by extensive primary and secondary research conducted by the research team.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. In the report, the analysis of the country is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to brings authenticity to the reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for drug manufacturing companies, medical device manufacturing companies, contract manufacturers, government organizations, and venture capitalists for the comprehensive market analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Germany Prostate Cancer Market Research and Analysis by Diagnostic Technique
2. Germany Prostate Cancer Market Research and Analysis by Therapy

The Report Covers

• Comprehensive research methodology of Germany Prostate Cancer Market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting Germany Prostate Cancer Market.
• Insights about market determinants which are stimulating Germany Prostate Cancer Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.